Rein Therapeutics Inc (RNTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.63M
Last updated: Nov 17, 2026 at 11:04 AM ET
Rein Therapeutics Inc (RNTX) Competitors
The companies most similar to Rein Therapeutics are NRX Pharmaceuticals (NRXP), RenovoRx (RNXT) and Rani Therapeutics Holdings (RANI). By market cap, Rein Therapeutics ranks 7th of the 13 companies on this page; NRX Pharmaceuticals (NRXP) is the largest at $95.58M.
Peer Comparison
RNTX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Rein Therapeutics (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NRX Pharmaceuticals Inc (NRXP) | $95.58M | N/A | 23.8x | 0.0% | N/A | 0.0% | 0.00% |
| RenovoRx Inc (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| Rani Therapeutics Holdings Inc (RANI) | $60.78M | N/A | 16.3x | 0.0% | N/A | 893.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Elicio Therapeutics Inc. (ELTX) | $42.46M | N/A | N/A | 0.0% | -96.6% | 0.0% | 0.00% |
| ProMIS Neurosciences Inc. (PMN) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $47.13M | N/A | 23.8x | 0.0% | -103.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Rein Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| NRX Pharmaceuticals Inc (NRXP) | NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company... | NRXP competitors |
| RenovoRx Inc (RNXT) | RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. | RNXT competitors |
| Rani Therapeutics Holdings Inc (RANI) | Rani Therapeutics Holdings Inc. is an innovative biotechnology company transforming the landscape of drug delivery with its proprietary RaniPill™ technology... | RANI competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| Elicio Therapeutics Inc. (ELTX) | Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment. | ELTX competitors |
| ProMIS Neurosciences Inc. (PMN) | ProMIS Neurosciences Inc. is a pioneering biotechnology company focused on the development of innovative therapeutic solutions for neurodegenerative diseases... | PMN competitors |
Frequently Asked Questions About RNTX
Who are Rein Therapeutics' main competitors?
The companies most similar to Rein Therapeutics include NRX Pharmaceuticals (NRXP), RenovoRx (RNXT), Rani Therapeutics Holdings (RANI), Gain Therapeutics (GANX) and Serina Therapeutics (SER), listed from the closest match.
Who is Rein Therapeutics' biggest competitor?
NRX Pharmaceuticals (NRXP) is both the largest of the similar companies at $95.58M and the closest match by business profile, size, sector and industry.
How does RNTX stock compare with its competitors?
RNTX's net margin is 0.0% against a peer median of 0.0%.
Which of Rein Therapeutics' competitors pays a higher dividend?
Rein Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Rein Therapeutics bigger than its competitors?
No. Rein Therapeutics is 7th by market cap among the 13 companies on this page; the largest is NRX Pharmaceuticals (NRXP) at $95.58M.
RNTX pages: Overview, Earnings, Forecast, Financials, Competitors